To support San Francisco’s Tobacco-Free Project in analyzing local data to report during community engagement meeting presentations, Facente Consulting analyzed datasets from the California Health Interview Survey (CHIS) and the Healthy Stores Healthy Communities (HSHC) Survey.
Project Descriptions
Tobacco Free Project Quantitative Data Analysis
Needs Assessment of Hepatitis C Testing and Treatment in the Jail System
End Hep C SF
Facente Consulting was selected by End Hep C SF to design and lead a mixed-methods needs assessment to identify gaps in hepatitis C (HCV) testing and treatment in San Francisco jails, identify best practices for treatment and linkage, and develop a HCV care cascade for people currently or recently incarcerated.
Project Coordination and Analytic Support to Improve Global HIV Incidence Estimation
The Consortium for the Evaluation and Performance of HIV Incidence Assays (CEPHIA)
Impact Evaluation of a Social Connection Intervention to Improve LGBTQ+ Mental Health
San Francisco Community Health Center
Planning and Facilitation of Institutes to Improve HIV PrEP Capacity in Florida
SFDPH Center for Learning and Innovation
Collective Impact Backbone Support and Data Analysis to Eliminate Hepatitis C
End Hep C SF
Evaluation for CDC-Funded Syringe Service Program Vaccine Scale-Up
NASTAD
Harm Reduction Readiness Assessment in Southeast San Diego
County of San Diego Public Health Services
Assistance to Develop a System of Panel Management within a Jail Medical System
SFDPH Jail Health Services
Statistical Support for an Advanced HIV Prevention Clinical Trial Design
Gilead Sciences
Facente Consulting supported Gilead Sciences with statistical analysis relating to HIV incidence rates, assisting with the study design, analysis plan, and interpretation of study data for the PURPOSE trials–ultimately leading to the groundbreaking FDA approval of the twice-yearly PrEP medication Lenacapavir.